N. Ermis Et Al. , "Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.," Biotechnic & histochemistry : official publication of the Biological Stain Commission , vol.98, no.5, pp.326-335, 2023
Ermis, N. Et Al. 2023. Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.. Biotechnic & histochemistry : official publication of the Biological Stain Commission , vol.98, no.5 , 326-335.
Ermis, N., Ulutas, Z., Ozhan, O., Yildiz, A., Vardi, N., Colak, C., ... Parlakpinar, H.(2023). Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.. Biotechnic & histochemistry : official publication of the Biological Stain Commission , vol.98, no.5, 326-335.
Ermis, Necip Et Al. "Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.," Biotechnic & histochemistry : official publication of the Biological Stain Commission , vol.98, no.5, 326-335, 2023
Ermis, Necip Et Al. "Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.." Biotechnic & histochemistry : official publication of the Biological Stain Commission , vol.98, no.5, pp.326-335, 2023
Ermis, N. Et Al. (2023) . "Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.." Biotechnic & histochemistry : official publication of the Biological Stain Commission , vol.98, no.5, pp.326-335.
@article{article, author={Necip Ermis Et Al. }, title={Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.}, journal={Biotechnic & histochemistry : official publication of the Biological Stain Commission}, year=2023, pages={326-335} }